Understanding the effects of latency reversing agents on HIV RNA splicing: implications for latency reversal SDF

被引：0
|
作者：
Mota, T. M. [1 ]
Khoury, G. [1 ]
Jacobson, J. C. [1 ]
Lu, H. K. [1 ]
Wightman, F. [1 ]
Van der Sluis, R. M. [1 ]
Anderson, J. L. [1 ]
Cameron, P. U. [1 ,2 ]
Lewin, S. R. [1 ,2 ]
Purcell, D. F. J. [1 ]
机构：
[1] Univ Melbourne, Doherty Inst Infect & Immun, Melbourne, Australia
[2] Alfred Hlth & Monash Univ, Dept Infect Dis, Melbourne, Australia
来源：
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY | 2016年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
THPDA0104
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Current Status of Latency Reversing Agents Facing the Heterogeneity of HIV-1 Cellular and Tissue Reservoirs
    Ait-Ammar, Amina
    Kula, Anna
    Darcis, Gilles
    Verdikt, Roxane
    De Wit, Stephane
    Gautier, Virginie
    Mallon, Patrick W. G.
    Marcello, Alessandro
    Rohr, Olivier
    Van Lint, Carine
    FRONTIERS IN MICROBIOLOGY, 2020, 10
  • [42] Toxicity and in vitro activity of HIV-1 latency-reversing agents in primary CNS cells
    Gray, Lachlan R.
    On, Hung
    Roberts, Emma
    Lu, Hao K.
    Moso, Michael A.
    Raison, Jacqueline A.
    Papaioannou, Catherine
    Cheng, Wan-Jung
    Ellett, Anne M.
    Jacobson, Jonathan C.
    Purcell, Damian F. J.
    Wesselingh, Steve L.
    Gorry, Paul R.
    Lewin, Sharon R.
    Churchill, Melissa J.
    JOURNAL OF NEUROVIROLOGY, 2016, 22 (04) : 455 - 463
  • [43] Epigenetic Regulation of HIV-1 Sense and Antisense Transcription in Response to Latency-Reversing Agents
    Li, Rui
    Caico, Isabella
    Xu, Ziyan
    Iqbal, Mohammad Shameel
    Romerio, Fabio
    NON-CODING RNA, 2023, 9 (01)
  • [44] Relationship between Measures of HIV Reactivation and Decline of the Latent Reservoir under Latency-Reversing Agents
    Petravic, Janka
    Rasmussen, Thomas A.
    Lewin, Sharon R.
    Kent, Stephen J.
    Davenport, Miles P.
    JOURNAL OF VIROLOGY, 2017, 91 (09)
  • [45] Dual TLR2 and TLR7 agonists as HIV latency-reversing agents
    Macedo, Amanda B.
    Novis, Camille L.
    De Assis, Caroline M.
    Sorensen, Eric S.
    Moszczynski, Paula
    Huang, Szu-han
    Ren, Yanqin
    Spivak, Adam M.
    Jones, R. Brad
    Planelles, Vicente
    Basque, Alberto
    JCI INSIGHT, 2018, 3 (19):
  • [46] New Latency Reversing Agents for HIV-1 Cure: Insights from Nonhuman Primate Models
    Bricker, Katherine M.
    Chahroudi, Ann
    Mavigner, Maud
    VIRUSES-BASEL, 2021, 13 (08):
  • [47] Reversal of Latency as Part of a Cure for HIV-1
    Rasmussen, Thomas Aagaard
    Tolstrup, Martin
    Sogaard, Ole Schmeltz
    TRENDS IN MICROBIOLOGY, 2016, 24 (02) : 90 - 97
  • [48] Implications of RNA Helicases in HIV-1 Replication: Possible Roles in Latency
    Ajamian, Lara
    Mouland, Andrew J.
    CURRENT HIV RESEARCH, 2011, 9 (08) : 588 - 594
  • [49] Molecular Understanding of HIV-1 Latency
    Abbas, W.
    Herbein, G.
    ADVANCES IN VIROLOGY, 2012, 2012
  • [50] Modeling the Effects of Latency Reversing Drugs During HIV-1 and SIV Brain Infection with Implications for the “Shock and Kill” Strategy
    Weston C. Roda
    Suli Liu
    Christopher Power
    Michael Y. Li
    Bulletin of Mathematical Biology, 2021, 83
12345